Tirzepatide with talking therapy for alcohol use and overweight
Treatments studied
Part of Hormones & metabolism, Mental health clinical trials.
This trial tests a medication called tirzepatide (which can help with weight loss) combined with talking therapy (cognitive-behavioural therapy) to help people reduce or stop drinking alcohol while also losing weight. It may be a good fit if you're overweight and want to change your drinking habits.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 21 and 75 years old.
- You should be drinking above a certain level each day (about 4 or more drinks for men, 3 or more for women) and want to reduce or stop.
- You need to be overweight, with a body mass index (BMI) of 27 or higher.
- You must be able to attend weekly clinic visits and speak English fluently.
- You should not have diabetes, significant mental health conditions, or severe liver or kidney problems.
- You shouldn't have used weight-loss or alcohol-treatment medications recently (in the past 3 months).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if tirzepatide, a medication that helps with appetite and blood sugar, can help people with alcohol use disorder drink less or stop drinking. You would visit the clinic regularly and receive the drug or a placebo.
This trial tests if tirzepatide, a diabetes drug, affects brain chemistry linked to alcohol use. Researchers want to see if it can help people with mild-to-moderate alcohol use disorder who also have tried stimulants.
This study tests whether a medication called tirzepatide (a once-weekly injection) can help people reduce their alcohol consumption. It is for people who drink heavily, have a high BMI, and are actively seeking help to drink less.
This trial tests if tirzepatide, a once-weekly injection, can help reduce heavy drinking in people who have both schizophrenia and alcohol use disorder. If you struggle with alcohol and have stable schizophrenia, this study may offer a new treatment option.
This trial tests if tirzepatide, a medication that helps with weight and blood sugar, can improve liver health in people with alcohol use disorder who also have fatty liver disease. It aims to reduce liver fat and related risks.
This study tests whether a weekly injection called tirzepatide (a drug used for diabetes and weight loss) can help people reduce their cannabis use. If you're interested in cutting down and have a higher body weight, this trial might offer a new approach.
Hear when a new Overweight or Obese trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.